Bicara Therapeutics BCAX Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's effective income tax rate reconciliation at federal statutory income tax rate, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's effective income tax rate reconciliation at federal statutory income tax rate, amount?
- Bicara Therapeutics (BCAX) reported effective income tax rate reconciliation at federal statutory income tax rate, amount of -$7.23M in Q4 2025.
- What does effective income tax rate reconciliation at federal statutory income tax rate, amount mean?
- This metric quantifies the total income tax expense or benefit recognized in the financial statements, serving as the starting point for the tax rate reconciliation. It reflects the final tax provision after accounting for all permanent and temporary differences. It is a primary indicator of the company's overall tax efficiency.